Login / Signup

Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A.

Praveen VikasLarissa A KordeMark R SomerfieldDawn L Hershman
Published in: JCO oncology practice (2022)
Keyphrases
  • early stage
  • sentinel lymph node
  • combination therapy
  • replacement therapy